Stay updated with breaking news from Luke Mountjoy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
John M. Burke, MD, expands on the use of novel BTK inhibitor regimens in mantle cell lymphoma, treatment sequencing challenges and other unmet needs in diffuse-large B-cell lymphoma, the evolution of management strategies for myeloproliferative neoplasms, and the potential influence of new and emerging therapeutics in chronic lymphocytic leukemia.
Choosing to climb a fourteener is a decision you, fortunately, can make on your own - being diagnosed with cancer, however, is not.
Choosing to climb a fourteener is a decision you, fortunately, can make on your own - being diagnosed with cancer, however, is not.
Choosing to climb a fourteener is a decision you, fortunately, can make on your own - being diagnosed with cancer, however, is not.
Choosing to climb a fourteener is a decision you, fortunately, can make on your own - being diagnosed with cancer, however, is not.